Autoimmune Encephalitis
📧 Sign up to get email alerts when something new happens for Autoimmune Encephalitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Safety and Pharmacodynamics of QH103 Cell Injection in the Treatment of Patients With Relapsed/Refractory Antibody-Mediated Neurological Autoimmune Diseases. [Phase 1]
Phase 1 clinical trial update assessing the safety and pharmacodynamics of QH103 cell injections in relapsed/refractory antibody-mediated ne…
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: FDG-PET in the Diagnosis of Autoimmune Encephalitis
A clinical trial is recruiting to evaluate the use of FDG-PET imaging to aid in diagnosing autoimmune encephalitis.
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Is [18F]-DPA-714 PET a Good Marker of Neuroinflammation in Autoimmune Encephalitis? [Phase 2]
This is a Phase 2 clinical trial investigating whether the PET tracer [18F]-DPA-714 can serve as a marker of neuroinflammation in autoimmune…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: Study of Pathogenic Mechanisms and Identification of Novel Autoantibodies in Autoimmune Encephalitis
This clinical trial update describes a study investigating pathogenic mechanisms and novel autoantibodies in autoimmune encephalitis, curren…
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: High-throughput Omic Technology for Identification of Biomarkers of Relapsing Acute Disseminated Encephalomyelitis in Immune Cell Network [NA]
A clinical trial investigating high-throughput omics to identify biomarkers in relapsing Acute Disseminated Encephalomyelitis and autoimmune…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: Phase 1 Study of ART5803 in Healthy Participants [Phase 1]
Phase 1 trial of ART5803 in healthy participants is active but not recruiting, sponsored by Arialys Therapeutics, with Autoimmune Encephalit…
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: CD19/BCMA-Targeted UCAR-T for Patients With Neurological Autoimmune Diseases [EARLY_Phase 1]
An early-phase UCAR-T therapy targeting CD19/BCMA is being evaluated for relapsing or refractory multiple sclerosis, myasthenia gravis, CIDP…
-
CLINICAL_TRIALS other · 2026-01-21Clinical Trial Update: Tongji NADs Cohort
Tongji Hospital has announced a NADs cohort trial covering multiple autoimmune neurological diseases including multiple sclerosis and relate…
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: A Study of C-CAR168 in the Treatment of Central Nervous System Autoimmune Diseases Refractory to Standard Therapy [Phase 1]
This is a Phase 1 clinical trial evaluating the safety and feasibility of C-CAR168 for CNS autoimmune diseases. The study is not yet recruit…
-
CLINICAL_TRIALS trial_result · 2025-12-23Clinical Trial Update: Long-term Impact of NMDAR Encephalitis
A completed clinical trial update examining the long-term outcomes of autoimmune encephalitis associated with NMDA receptor antibodies.
-
CLINICAL_TRIALS research · 2025-12-15Clinical Trial Update: Universal Chimeric Antigen Receptor T-Cell （UCAR T-cell） Therapy Targeting CD19/B Cell Maturation Antigen （CD19/BCMA） in Patients With r/r Neurological Autoimmune Diseases [EARLY_Phase 1]
A Phase 1 trial evaluating a universal CAR T-cell therapy targeting CD19 and BCMA in relapsed/refractory neurological autoimmune diseases, w…
-
CLINICAL_TRIALS research · 2025-09-25Clinical Trial Update: Phase 1 Study of ART5803 Safety and PK After IVIG in Healthy Participants [Phase 1]
Phase 1 trial update for ART5803 assessing safety and pharmacokinetics after IVIG in healthy participants.
-
CLINICAL_TRIALS trial_result · 2025-09-05Clinical Trial Update: Monitoring of Outcomes of Cellular and Exosome-based Therapies in Autoinflammatory and Post-infectious Neuroinflammatory Syndromes
Biocells Medical reports ongoing monitoring of outcomes for cellular and exosome-based therapies in autoinflammatory and post-infectious neu…
-
CLINICAL_TRIALS research · 2025-09-04Clinical Trial Update: Trial to Evaluate Efficacy and Safety of Bortezomib in Patients With Severe Autoimmune Encephalitis [Phase 2]
Phase 2 clinical trial evaluating the efficacy and safety of bortezomib in patients with severe autoimmune encephalitis, currently recruitin…
-
CLINICAL_TRIALS research · 2025-08-27Clinical Trial Update: A Prospective Study to Evaluate Clinical Outcomes in Anti-LGI1 Encephalitis
A prospective clinical trial is evaluating clinical outcomes in anti-LGI1 autoimmune encephalitis and is currently recruiting.
-
CLINICAL_TRIALS research · 2025-08-27Clinical Trial Update: Neural Autoantibody Prevalence in New-onset Focal Seizures of Unknown Etiology
A clinical trial is evaluating how common neural autoantibodies are in people with new-onset focal seizures of unknown etiology, and it is c…
-
CLINICAL_TRIALS research · 2025-08-22Clinical Trial Update: Impact of Confirmed Autoimmune Encephalitis on Brain Glucose Metabolism [NA]
A clinical trial sponsored by Assistance Publique - Hôpitaux de Paris is investigating how confirmed autoimmune encephalitis affects brain g…
-
CLINICAL_TRIALS research · 2025-08-20Clinical Trial Update: hUC-MSC-Exo Therapy for Autoimmune Encephalitis [Phase 1, Phase 2]
Update on a planned Phase 1/2 clinical trial evaluating hUC-MSC-Exo therapy for autoimmune encephalitis, which is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2025-08-14Clinical Trial Update: Efficacy and Safety of Adjunctive Minocycline in the Treatment of Autoimmune Encephalitis [Phase 2]
Phase 2 trial evaluating adjunctive minocycline with standard care for autoimmune encephalitis has completed, assessing efficacy and safety.
-
CLINICAL_TRIALS research · 2025-07-30Clinical Trial Update: A Study in Participants With Anti-NMDAR Encephalitis and Anti-NMDAR Antibody-Associated Psychiatric Disease [Phase 2]
Phase 2 clinical trial for Anti-N-methyl-D-aspartate receptor encephalitis and anti-NMDA receptor antibody-associated psychiatric disease; t…
-
CLINICAL_TRIALS trial_result · 2025-06-27Clinical Trial Update: CPI Combination Therapy for Autoimmune Encephalitis [NA]
The clinical trial evaluating a CPI combination therapy for autoimmune encephalitis has completed.
-
CLINICAL_TRIALS trial_result · 2025-06-26Clinical Trial Update: Clinical Characteristics of Patients With Anti-Collapsin Response Mediator Protein 2 Antibodies in Encephalitis or Encephalomyelitis
This completed trial update reports on the clinical characteristics of patients with anti-Collapsin response mediator protein 2 (CRMP-2) ant…
-
CLINICAL_TRIALS research · 2025-04-08Clinical Trial Update: Efficacy and Safety of Calculus Bovis Sativus (CBS) for Adult Encephalitis (CBSinEncephalitis) [NA]
A clinical trial evaluating the efficacy and safety of Calculus Bovis Sativus for adults with encephalitis, including viral and autoimmune f…
-
CLINICAL_TRIALS research · 2025-03-30Clinical Trial Update: IVIG and Rituximab in Antibody-associated Psychosis - SINAPPS2 [Phase 2]
Phase 2 clinical trial SINAPPS2 evaluates intravenous immunoglobulin (IVIG) and rituximab for antibody-associated psychosis linked to autoim…
-
CLINICAL_TRIALS trial_result · 2025-01-10Clinical Trial Update: Neuro-ophthalmology and Autoimmune Encephalitis (NODE)
Clinical trial NODE study investigating autoimmune encephalitis with neuro-ophthalmology aspects has completed.